Fairvalue-Calculator Fairvalue-Calculator

Meiji Holdings (MEJHY) Fair Value & Analysis

Consumer Defensive · US · Market cap $6.1B

Price$11.21
Fair Value$9.88
Upside-11.9%
Quality91/100
Evidence: Medium Range $8.45 – $11.16

Analysis

Meiji Holdings (MEJHY) currently trades at $11.21, while our model-based Fair Value estimate is $9.88 — implying the stock looks roughly 11.9% overvalued today. We read business quality at 91/100 (high quality), in the Consumer Defensive sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

About the company

Meiji Holdings Co., Ltd., through its subsidiaries, engages in the manufacture and sale of dairy products, confectionery food products and pharmaceuticals in Japan and internationally. The company operates through two segments, Food and Pharmaceuticals. The Food segment provides yogurt, milk, beverages, cheese, butter, margarine, cream, ice cream, prepared food, chocolate, gummy candy, sports nutrition, infant milk, liquid food, beauty products, feed, sugar, and corn sweeteners. The Pharmaceutical segment offers drugs for infectious and central nervous system disorders, vaccines, blood plasma products, generic drugs, and animal health products. Meiji Holdings Co., Ltd. was founded in 1916 and is headquartered in Tokyo, Japan.

Open the full interactive analysis →

Similar stocks

Nestlé S.A (NSRGF) -33% Foshan Haitian Flavouring and Food Company (603288) -28% Nestlé India Limited (NESTLEIND) -75% Grupo Bimbo, S.A. (BIMBOA) -21% Uni-President Enterprises Corp (1216) -27% Britannia Industries Limited (BRITANNIA) -62%

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.